Detailed Information on Publication Record
2005
Blood Pressure and Baroreflex Sensitivity after Anthracycline Chemotherapy in Childhood with Respect to Fatty Acid Metabolism
ZÁVODNÁ, Eva, Hana HRSTKOVÁ, Pavla BALCÁRKOVÁ, Zuzana NOVÁKOVÁ, Nataša HONZÍKOVÁ et. al.Basic information
Original name
Blood Pressure and Baroreflex Sensitivity after Anthracycline Chemotherapy in Childhood with Respect to Fatty Acid Metabolism
Name in Czech
Krevní tlak a citlivost baroreflexu u dětí a adolescentů po chemoterapii antracykliny vzhledem k metabolismu lipidů
Authors
ZÁVODNÁ, Eva (203 Czech Republic, guarantor), Hana HRSTKOVÁ (203 Czech Republic), Pavla BALCÁRKOVÁ (203 Czech Republic), Zuzana NOVÁKOVÁ (203 Czech Republic), Nataša HONZÍKOVÁ (203 Czech Republic) and Bohumil FIŠER (203 Czech Republic)
Edition
Scripta medica, Brno, Masarykova univerzita, Lékařská fakulta, 2005, 1211-3395
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30105 Physiology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/05:00019033
Organization unit
Faculty of Medicine
Keywords (in Czech)
Antracyklin, krevní tlak, baroreflex, variabilita srdeční frekvence, cholesterol
Keywords in English
Anthracycline; Blood pressure; Baroreflex sensitivity; Heart rate variability; Cholesterol
Změněno: 19/6/2009 12:18, prof. MUDr. Bohumil Fišer, CSc.
V originále
Late effects of caardiotoxic therapy on childhood cancer were studied. Body and circulation parameters were compared in 206 helathy controls, and 97 children and adolescents after antitumour treatment at the age of 11 - 21 years with respect to plasma lipid level. The subjects after antitumour therapy had increased parasympathetic and decreased sympathetic tonic activity together with decreased baroreflex sensitivity. The increase of inter-beat interval variability was neither the result of a primary increase of vasomotor activity nor an increase of baroreflex sensitivity response to changes in blood pressure. We can explain it by increasing parasympathetic control of the heart. The circulatory changes did not bear on obesity, but they were rather a specific effect of tumour disease and antitumou treatment.
In Czech
Studovali jsme pozdní efekt kardiotoxické terapie dětských nádorových onemocnění. Dětští pacienti po prodělané protinádorové léčbě měli zvýšenou parasympatickou a sníženou sympatickou aktivitu spojenou se sníženou citlivostí baroreflexu.
Links
NR8006, research and development project |
|